Literature DB >> 12878727

Coevolutionary patterns in plasminogen activation.

Inna P Gladysheva1, Ryan B Turner, Irina Y Sazonova, Lin Liu, Guy L Reed.   

Abstract

The generation of plasmin by plasminogen (Pg) activators (PAs) is a physiologic process in animals that dissolves blood clots and promotes wound healing, blood vessel growth, and the migration of normal and cancerous cells. Pathogenic bacteria have evolved PAs [e.g., streptokinase (SK) and staphylokinase] that exploit the Pg system to infect animals. Animal PAs have a conserved ability to cleave a wide spectrum of animal Pgs, but the ability of bacterial PAs to cleave different animal Pgs is surprisingly restricted. We show that the spectrum of activity of an archetypal bacterial PA (SK) with animal Pgs can be profoundly altered by mutations that affect intermolecular complementarity at sites that participate in complex formation or substrate binding. Comparative sequence analysis of animal plasmins vs. close structural homologues (trypsin and chymotrypsin) that are not molecular targets for invading bacteria indicates that the sites in plasmin that interact with SK are preferentially targeted for mutation. Conversely, intermolecular contact sites in SKs that activate human Pg are more highly conserved than other loci in the molecule or than the same sites in other SKs that activate non-human Pgs. We propose that active modulation of intermolecular complementarity at sites of contact between SK and Pg may represent a competitive evolutionary strategy in a survival battle, whereby animals seek to evade bacterial invasion, and bacteria endeavor to invade their animal hosts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12878727      PMCID: PMC170890          DOI: 10.1073/pnas.1631716100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  The strategy of blocking the chemokine system to combat disease.

Authors:  A E Proudfoot; C A Power; T N Wells
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

2.  Co-evolution of proteins with their interaction partners.

Authors:  C S Goh; A A Bogan; M Joachimiak; D Walther; F E Cohen
Journal:  J Mol Biol       Date:  2000-06-02       Impact factor: 5.469

3.  A surface protease and the invasive character of plague.

Authors:  O A Sodeinde; Y V Subrahmanyam; K Stark; T Quan; Y Bao; J D Goguen
Journal:  Science       Date:  1992-11-06       Impact factor: 47.728

4.  Staphylokinase; an activator of plasma protease.

Authors:  C H LACK
Journal:  Nature       Date:  1948-04-10       Impact factor: 49.962

5.  Crystal structure of the catalytic domain of human plasmin complexed with streptokinase.

Authors:  X Wang; X Lin; J A Loy; J Tang; X C Zhang
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

6.  Correlated mutations contain information about protein-protein interaction.

Authors:  F Pazos; M Helmer-Citterich; G Ausiello; A Valencia
Journal:  J Mol Biol       Date:  1997-08-29       Impact factor: 5.469

Review 7.  Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system.

Authors:  P Carmeliet; D Collen
Journal:  Thromb Haemost       Date:  1995-07       Impact factor: 5.249

8.  Zymogen activation in the streptokinase-plasminogen complex. Ile1 is required for the formation of a functional active site.

Authors:  S Wang; G L Reed; L Hedstrom
Journal:  Eur J Biochem       Date:  2000-07

9.  Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model.

Authors:  Z Li; V A Ploplis; E L French; M D Boyle
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

10.  Identification of a plasminogen binding region in streptokinase that is necessary for the creation of a functional streptokinase-plasminogen activator complex.

Authors:  G L Reed; L F Lin; B Parhami-Seren; P Kussie
Journal:  Biochemistry       Date:  1995-08-15       Impact factor: 3.162

View more
  26 in total

1.  Structural diversity of streptokinase and activation of human plasminogen.

Authors:  Sergio Lizano; Kenneth H Johnston
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

2.  Polymorphisms in Regulator of Cov Contribute to the Molecular Pathogenesis of Serotype M28 Group A Streptococcus.

Authors:  Paul E Bernard; Priyanka Kachroo; Jesus M Eraso; Luchang Zhu; Jessica E Madry; Sarah E Linson; Matthew Ojeda Saavedra; Concepcion Cantu; James M Musser; Randall J Olsen
Journal:  Am J Pathol       Date:  2019-07-29       Impact factor: 4.307

3.  Reprogrammed streptokinases develop fibrin-targeting and dissolve blood clots with more potency than tissue plasminogen activator.

Authors:  I Y Sazonova; R A McNamee; A K Houng; S M King; L Hedstrom; G L Reed
Journal:  J Thromb Haemost       Date:  2009-06-30       Impact factor: 5.824

4.  Fibrin-targeted plasminogen activation by plasminogen activator, PadA, from Streptococcus dysgalactiae.

Authors:  Satish Singh; Timsy Bhando; Kanak L Dikshit
Journal:  Protein Sci       Date:  2014-04-05       Impact factor: 6.725

5.  The fruRBA Operon Is Necessary for Group A Streptococcal Growth in Fructose and for Resistance to Neutrophil Killing during Growth in Whole Human Blood.

Authors:  Kayla M Valdes; Ganesh S Sundar; Luis A Vega; Ashton T Belew; Emrul Islam; Rachel Binet; Najib M El-Sayed; Yoann Le Breton; Kevin S McIver
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

6.  The Bfp60 surface adhesin is an extracellular matrix and plasminogen protein interacting in Bacteroides fragilis.

Authors:  Eliane de Oliveira Ferreira; Felipe Lopes Teixeira; Fabiana Cordeiro; Leandro Araujo Lobo; Edson R Rocha; Jeffrey C Smith; Regina M C P Domingues
Journal:  Int J Med Microbiol       Date:  2013-06-21       Impact factor: 3.473

7.  Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates.

Authors:  Tadayoshi Ikebe; Manabu Ato; Takayuki Matsumura; Hideki Hasegawa; Tetsutaro Sata; Kazuo Kobayashi; Haruo Watanabe
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

8.  Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential.

Authors:  Livia S Machado; Irina Y Sazonova; Anna Kozak; Daniel C Wiley; Azza B El-Remessy; Adviye Ergul; David C Hess; Jennifer L Waller; Susan C Fagan
Journal:  Stroke       Date:  2009-07-23       Impact factor: 7.914

9.  Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis.

Authors:  Marissa H Braff; Amanda L Jones; Shawn J Skerrett; Craig E Rubens
Journal:  J Infect Dis       Date:  2007-03-15       Impact factor: 5.226

Review 10.  Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.

Authors:  Alexander Laarman; Fin Milder; Jos van Strijp; Suzan Rooijakkers
Journal:  J Mol Med (Berl)       Date:  2010-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.